Ignite Creation Date:
2024-05-06 @ 2:36 PM
Last Modification Date:
2024-10-26 @ 1:34 PM
Study NCT ID:
NCT04368507
Status:
COMPLETED
Last Update Posted:
2022-11-14
First Post:
2019-11-24
Brief Title:
To Evaluate the Safety Tolerability Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients
Sponsor:
CellabMED
Organization:
CellabMED
Organization Data
Organization:
CellabMED
Class:
INDUSTRY
Study ID:
NOV110501-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CellabMED
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Yooyoung Pharmaceutical Co Ltd | INDUSTRY |